Post-ischemic long-term potentiation (i-LTP) is a pathological form of plasticity that was observed in glutamate receptor-mediated neurotransmission after stroke and may exert a detrimental effect via facilitating excitotoxic damage. The mechanism underlying i-LTP, however, remains less understood. By employing electrophysiological recording and immunofluorescence assay on hippocampal slices and cultured neurons, we found that protein kinase Mf (PKMf), an atypical protein kinase C isoform, was involved in enhancing aminomethyl phosphonic acid (AMPA) receptor (AMPAR) expression after i-LTP induction. PKMf knockdown attenuated postsynaptic expression of AMPA receptors and disrupted i-LTP. Consistently, we observed less neuronal death of cultured hippocampal cells with PKMf knockdown. Meanwhile, these findings indicate that PKMf plays an important role in i-LTP by regulating postsynaptic expression of AMPA receptors. This work adds new knowledge to the mechanism of i-LTP, and thus is helpful to find the potential target for clinical therapy of ischemic stroke.
Introduction
The interruption of blood supply to the brain leads to ischemic stroke. As one of the leading causes of death and adult disability in the world, ischemic stroke draws more and more theoretical and clinical research [1] .
However, the mechanisms underlying ischemic damage in the brain are still less understood. After stroke, glutamate receptor mediated pathological neural plasticity termed post-ischemic long-term potentiation (i-LTP) often occurs [2] [3] . Although such neural plasticity plays roles in recovery [4] , excessive calcium entry and related kinase responses involved facilitate excitotoxicity and further damages. Therefore, improving the understanding of mechanisms mediating i-LTP after stroke is urgent. It is well known that AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) -type glutamate receptors (AMPARs) mediate main neurotransmission in i-LTP [3] . AMPARs are heteromeric channels composed of GluA1-4 subunits. GluA2-containing AMPARs are calcium-impermeable, and AMPARs lacking GluA2 are calcium-permeable (CP-AMPARs) [5] . It is reported that GluA2-containing AMPARs are rapidly internalized after oxygen and glucose deprivation (OGD, a widely used ischemic model in vitro, mimicking the lack of oxygen and glucose in ischemic stroke), which are replaced by CP-AMPARs [6, 7] . Excessive expression of CP-AMPARs in i-LTP results in more calcium and Zn 2+ entry and excitotoxicity during stroke [8] [9] [10] . In fact, inhibitors of AMPARs (such as NBQX) and special inhibitors of CP-AMPARs (such as NAPSM) can effectively prevent cell death due to ischemia [11] . Almost certainly, the persistent increase of CP-AMPAR expression after ischemia plays an important role in i-LTP-induced neuronal damage. Therefore, the mechanisms underlying the regulation of CP-AMPAR expression in i-LTP need to be addressed.
In physiological conditions, development, learning and environment challenges can also induce long-term changes of synaptic transmission. The postsynaptic membrane expression of AMPARs is also the key step in this kind of LTP. It has been demonstrated that many molecular mechanisms involved in physiological LTP are similar to those for pathological changes [4] . The postsynaptic expression of AMPARs is regulated by several protein kinases, such as protein kinase C (PKC), cAMP-dependent protein kinase A (PKA) and Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) [12] . In the past decade, PKMf, a brainspecific autonomously active isozyme of PKC, has been studied extensively and regarded as the key molecule to maintain physiological LTP and many types of memories [13] . It sustained LTP by increasing the number of AMPARs at postsynaptic sites. In addition, PKMf maintaining long-term changes of neurotransmission could mediate several neurological and psychiatric disorders, exemplified by chronic neuropathic pain [14] [15] and post-traumatic stress disorder [16] . It is interesting to know whether PKMf also participates in i-LTP and ischemia-induced enhancement in postsynaptic expression of AMPARs.
Hippocampal CA1 area is one of the most vulnerable regions [17] [18] after global ischemic stroke. In this work, we employed electrophysiological recording and Western blotting assay on OGD treated hippocampal slices and cultured neurons. We observed that i-LTP was accompanied by enhancement of postsynaptic expression of GluA1 and PKMf. By injecting short hairpin RNA (shRNA) targeting PKMf delivered by lentiviruses, OGD-induced i-LTP was suppressed by PKMf knockdown and the localization of GluA1 at postsynaptic sites was decreased. Furthermore, neuron survival after OGD was also increased after PKMf knockdown. Our data deepens the knowledge of pathological plasticity after cerebral ischemia and provides useful experimental clues for stroke therapeutics.
Materials and methods

Hippocampal slice preparation
All animals and experimental protocols were carried out by the guidance of the National Institutes of Health for the Care and Use of Laboratory Animals. Male Sprague-Dawley (SD) rats (4-6 weeks old) were anesthetized with 10% chloral hydrate followed by decapitation. The entire brain was rapidly removed. Coronal hippocampal brain slices (350 mm) were prepared by a vibratome (VT1000S, Leica, Germany) in ice-cold artificial cerebrospinal fluid (ACSF) containing (in mmol/L) 125 NaCl, 3.25 KCl, 2 CaCl 2 , 25 NaHCO 3 , 1.25 NaH 2 PO 4 and 11 glucose (pH57.4). The ACSF was saturated with 95% O 2 and 5% CO 2. And fresh slices were recovered in oxygenated ACSF at 34 uC for at least 1 hour before experiments.
Intracranial virus injection
ShRNA (59-ACATTAAGCTGACGGACTA-39) targeting PKMf (PKMf-shRNA) and the scrambled shRNA (59-CATGTAAGACGACTATGAC-39, scrshRNA) were packaged in lentiviruses (Neuron Biotech, Shanghai, China). For intracranial virus injections, male SD rats, 4-6 weeks old, were deeply anesthetized with 10% chloral hydrate. Then, rats were fixed on a stereotaxic frame (RWD Life Science, Shenzhen, Guangdong, China). The 10 mL syringe was stereotaxically targeted to the dorsal hippocampus CA1 region (AP: -4.56 mm relative to bregma; ML:¡3.0 mm; DV: 3.0 mm [19] ). Injections were carried out at a rate of 1 mL/minute, and controlled by a microsyringe pump controller (WPI, Sarasota, FL, USA). The needle was left in place for 6 additional minutes after virus injection. Rats were allowed 7 days to recover before electrophysiological recording or Western blotting assays.
Primary hippocampal cell culture and transfection
Primary hippocampal cultures were prepared from E18-19 rats as previously described [20] and grown in neurobasal medium supplemental with 2% B27 (Gibco) and 1% Glutamax (Life Technologies, Carlsbad, CA, USA). Neurons were grown on coverslips coated with poly-D-lysine (0.1 g/L, SigmaAldrich, St Louis, MO, USA) in 12-well plates and cultured in humidified atmosphere with 5% CO 2 at 37 uC. For transfection of PKMf-shRNA and scrambled (scr)-shRNA, lentiviruses were added into wells at DIV8-10.
Electrophysiological recordings
Field excitatory postsynaptic potential (fEPSP) recording on acute hippocampal slices were performed with Axopatch-200B/700B amplifier (Molecular Device, Sunnyvale, CA, USA) and recorded from the stratum radiatum of CA1 in ACSF perfusion medium containing bicuculline methiodide (10 mmol/L). OGD was applied by 95% N 2 /5% CO 2 in an ACSF solution containing 11 mmol/L sucrose for 3 minutes.
Whole-cell recordings were made from DIV10 -14 cultured neurons as previously described [21] [22] . Cells were voltage clamped at -65 mV. Patch pipettes were filled with electrolyte solution containing (in mmol/ L) 140 CsCl, 2.5 EGTA, 2 MgCl 2 , 10 HEPES, 2TEA and 4 K 2 ATP (pH57.4). Cells were perfused continuously with extracellular solution (ECS) containing (in mmol/L) 140 NaCl, 1.3 CaCl 2 , 5 KCl, 25 HEPES, 33 glucose, 1 MgCl 2 , 0.01 bicuculline methiodide and 0.0005 TTX (pH57.4). Miniature excitatory postsynaptic currents were continuously recorded using an Axopatch-700B amplifier and records were filtered at 2 kHz. OGD-induced i-LTP was made as the protocol on slice, anoxia/hypoglycemia by 95% N 2 /5% CO 2 and ECS containing 33 mmol/L sucrose instead of glucose for 3 minutes.
Western blotting assay
Hippocampal slices were prepared as described above. Slices were then incubated in ACSF at 34 uC (95% O 2 and 5% CO 2 ) for 40 minutes. After incubation, slices were treated with OGD for 3 minutes, and recovered in normal ACSF for 30 minutes. Then, slices were homogenized in cold 0.32 mol/L sucrose containing (in mmol/L) 1 HEPES, 1 MgCl 2 , 1 NaHCO 3 , 20 sodium pyrophosphate, 20 b-phosphogrycerol, 0.2 dithiothreitol, 1 EDTA, 1 EGTA, 50 NaF, 1 Na 3 VO 4 and 1 p-nitrophenyl phosphate (PNPP, pH57.4) in the presence of protease and phosphatase inhibitors. The homogenate was centrifuged at 1,000 6 g for 10 minutes. The supernatant was collected for subsequent analysis.
For Western blotting assay, samples were heated for 5 minutes at 95 uC with 5 6 SDS loading buffer, subjected to SDS-PAGE and transferred to a PVDF membrane. Then, they were blocked with 3% (w/v) BSA (fraction V) in Tris buffered saline Tween (TBST, 0.1% Tween 20) for 1 hour at room temperature and analyzed by immunoblotting with the following antibodies: mouse monoclonal anti-GluR1-NT antibody (MAB2263; Millipore, Billerica, MA, USA), rabbit monoclonal anti-PSD95 (N-term) antibody (04-1066; Millopore), rabbit polyclonal anti-PKCf (PKMf) antibody (sc-216, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and mouse monoclonal anti-b-Tubulin antibody (Beyotime, Beijing, China).
Immunofluorescence assay
The coverslips with cultured hippocampal neurons were incubated with the ECS at 37 uC for 30 minutes before experiments. The cultures were exposed to a transient OGD (3 minutes), and recovered in ECS at 37 uC for 20 minutes, and then were fixed with 4% paraformaldehyde for 30 minutes. After wash with PBS and blocking in 10% (w/v) FBS (Gibco), the neurons were labeled with GluA1 and PSD95 antibody (Millipore) overnight at 4 uC with 0.1 % Triton X-100 in PBS containing 10 % FBS. Then, neurons were incubated with Alexa 647 and Alexa 568 conjugated secondary antibody for visualizing GluA1 and PSD95, respectively. The coverslips were washed and fixed with ProLong Gold Antifade reagent (Life Technologies, Grand Island, NY, USA). Neurons were imaged using a Zeiss LSM710 laser scanning confocal microscope (Carl Zeiss, Jena, Germany) under identical conditions and analyzed using same parameters. The colocalization was determined by examination of the overlaid GluA1 and PSD95-stained image in 50 mm dendritic shaft (about 30 mm away from the cell body). The results were processed and analyzed by Fiji software (NIH, USA). The pearson9s R values were obtained and analyzed with ANOVA least significant difference (LSD) for statistical significance and are expressed as means ¡ SE.
Nuclear staining
After 45-minute OGD exposure, cultures were fixed with 4% paraformaldehyde for 30 minutes, washed with PBS, and stained with Hoechst 33342 (0.5 mg/L) and propidium iodide (PI; 4 mg/L) for 1 hour before confocal imaging (LSM710, Zeiss). The number of PI or Hoechst positive nuclei was counted (Fiji software) to determine cell viability.
Data analysis
Data were expressed as mean¡SEM. Withingroup comparisons was determined by paired-sample t-test, and differences between groups were compared using independent-sample t-test (two populations) and ANOVA post-hoc comparisons. Differences were considered significant when P was ,0.05, and the significance for homogeneity of variance test was set at 0.1.
Results
I-LTP and the increases of GluA1 and PKMf expression induced by OGD
To evaluate the pathological plasticity induced by OGD, we recorded the extracellular field potential in acute hippocampal slices. After perfusion of slices with OGD solution for 3 minutes, a persistent increase of fEPSP amplitude ( Fig. 1A; 1.33 ¡ 0.08) was recorded. According to previous studies, the augmentation of neurotransmission was mediated by the postsynaptic expression of GluA2-lacking CP-AMPARs mainly [23] . Therefore, GluA1 should be the primary AMPAR subunit which inserts into the postsynaptic membrane after OGD. Using Western blotting assay of the hippocampus tissue, we detected increased postsynaptic GluA1 expression ( Fig. 1B; 1 .12 ¡ 0.03) 30 minutes after OGD. Interestingly, we found a paralleled enhancement in PKMf expression at the same time after OGD ( Fig. 1B; 1.18¡0.04) . Thus, we hypothesized that the enhancement in PKMf expression may correlate with enhancement in GluA1 and possibly play a role in i-LTP.
The inhibition of i-LTP by PKMf knockdown
To investigate the possible role of PKMf in i-LTP, we specifically knockdown PKMfs by delivering lentivirus-packed PKMf-shRNA into hippocampal slices. Green fluorescent protein (GFP) was constructed with shRNA to ensure the successful expression of shRNA. As shown in Fig. 2A and Fig. 3A , seven days (for intracranial injection) or three days (for transfetcion of cultured neurons) after lentivirus infection, GFP was expressed efficiently in both acute hippocampal slices and cultured neurons. Western blotting assays showed that the expression of PKMf was knocked down by the shRNA efficiently (Fig. 2B) .
After the injection of lentiviruses expressing PKMfshRNA or scr-shRNA into bilateral dorsal hippocampus, acute hippocampus slices were prepared and fEPSP recording was performed in the hippocampal CA1 cells with green fluorescence. As shown in Fig. 2C and 2D , after transient OGD exposure, the fEPSP amplitude was increased in naive slices (1.33 ¡ 0.08) and scr-shRNA transfected slices (1.35 ¡ 0.07). There was no significant difference between the two groups. However, i-LTP was suppressed in PKMf knockdown preparations (0.98¡0.03). At the same time, the effect of PKMf knockdown on i-LTP was also tested in primary cultured neurons. During OGD solution perfusing, whole-cell recording of mEPSC was performed on the cultured hippocampal neurons transfected with PKMf-shRNA or not. As shown in Fig. 3B and 3C , consistent with the performance in slices, OGD treatment increased the mEPSC amplitude in control samples (1.22 ¡ 0.04), but did not significantly alter the amplitude in transfected neurons (0.94 ¡ 0.03). There was still obvious augmentation of mEPSC on the scr-shRNA transfecting neurons treated by OGD solution (1.20 ¡ 0.02). The above data showed that PKMf knockdown suppressed i-LTP both in acute slices and cultured neurons. Therefore, PKMf was found to participate in OGD-induced synaptic plasticity.
The involvement of PKMf in postsynaptic expression of GluA1 during i-LTP
In physiological synaptic plasticity, LTP is mostly caused by AMPAR insertion into the postsynaptic membrane [24] . Substantial evidence supports a role for PKMf in this process. PKMf affects maintenance of LTP mainly by regulating the surface trafficking of AMPARs [25] . To assess the synaptic targeting of GluA1 under OGD and PKMf knockdown, immunofluorescence assay was employed on cultured hippocampal neurons. The expression of GluA1 in postsynaptic sites was determined by quantifying the degree of colocalization of GluA1 and PSD95 (a postsynaptic marker). The confocal fluorescent images are shown in Fig. 4A . An increased colocalization between GluA1 and PSD95 was observed, indicating that GluA1 was targeted to postsynaptic sites after OGD (Fig. 4B) , which was aborted in neurons with PKMf knockdown. No significant difference was observed between the control and the group transfected with scr-shRNA. These data suggested that OGD-induced i-LTP is mediated by increased expression of AMPARs at postsynaptic sites and PKMf is involved in the regulation of AMPAR localization after OGD. We deduced that PKMf plays a role in i-LTP through regulating postsynaptic expression of AMPARs. 
Reducing neuronal death by PKMf knockdown
The data above had revealed that PKMf regulated the postsynaptic expression of GluA1 during i-LTP. GluA1 was thought to be the main fraction of CP-AMPARs, which mediate calcium entry and excitotoxicity in ischemic stroke [8] [9] . To further investigate the functional relevance of PKMf during OGD, cultured neurons were transfected with PKMf-shRNA, and were subjected to OGD for 45 minutes. Then, cell death was analyzed by nuclear staining. The number of PI or Hoechst positive nuclei was counted to determine cell viability. The confocal images and statistical results are shown in 
Discussion
LTP is observed during many physiological and pathological processes [26] [27] . PKMf is well known as a key regulator in the maintenance of physiological LTP. The presence and distribution of PKMf in the brain and the function of PKMf in memory have been extensively studied in recently years [13, [28] [29] [30] . It is involved in AMPAR trafficking and expression at postsynaptic sites, which is the basic molecular mechanism underlying the increase of synaptic transmission. However, the mechanism of pathological LTP is still less understood. Especially, i-LTP after ischemic stroke, which affects the lives of millions of people every year, is needed to be intensively dissected. A few studies have reported the roles of PKMf in nerve disease, such as persistent pain [14] , chronic pain [15] and cervical spinal injury [31] , suggesting the possible involvement of PKMf in i-LTP. In this study, the data showed that PKMf was up-regulated in hippocampal CA1 regions in ischemic model. PKMf knockdown suppressed OGD-induced i-LTP in both hippocampal slices and cultured neurons. GluA1 subunit of AMPARs was selected to be analyzed due to its primary role in the potentiation of the neurotransmission during i-LTP. Indeed, the postsynaptic expression of GluA1 was attenuated by PKMf knockdown. PICK1 is a PDZ domain-containing protein, which can bind to AMPARs via the PDZ domain [32] and regulate CP-AMPAR plasticity [33, 34] . It was reported that the increase of GluA2-lacking AMPARs at synapses during OGD could be inhibited by disrupting the interactions of PICK1 PDZ domain. It was thought that this mechanism was involved in OGD-induced cell death [35] . Moreover, the C-terminal of PKMf contains a PDZ-binding sequence that interacts with PICK1 [36] . Therefore, PKMf may regulate AMPAR trafficking in i-LTP via PICK1. Like other PKC isoforms, PKMf is a serine and threonine kinase. It is possible that PKMf regulates AMPAR expression by facilitating the phosphorylation of AMPAR, such as at S831 at GluA1 or S880 at GluA2. The details involved in the regulation of AMPARs by PKMf will be further studied in the future. Furthermore, the switch from GluA2-containing AMPARs to CP-AMPARs is a main cause of ischemic injury [8] [9] . GluA1-containing AMPARs mediate the main excitotoxicity during hippocampal ischemia. Therefore, it was hypothesized that PKMf was participated in the ischemic damage by facilitating GluA1 expression at postsynaptic sites. Indeed, using OGD and cell viability test, PKMf knockdown can prevent cell death. In fact, other PKC family proteins in ischemia and hypoxia are studied widely. PKCs were reported to be altered during these processes [37] [38] . PKC activity was significantly affected during the very early phase of cerebral ischemia [39] [40] . As it is well known, in response to diverse signal pathways, different PKC isoforms can play multiple roles in different physiological processes and functions [37] . It is possible that all PKCs are participated in ischemia in different processes. Like in the physiological LTP, PKMf might mainly take its role in the later phase of ischemia, but not in the early phase. All of these need to be further investigated.
In conclusion, we have shown that PKMf plays an important role in i-LTP by regulating postsynaptic expression of AMPARs, just like its contribution to the maintenance of physiological LTP. Furthermore, PKMf is involved in ischemic damage by facilitating GluA1 expression at postsynaptic sites. The results are helpful to understand molecular mechanisms underlying cellular damage after ischemic stroke and provide a new clue to further study in clinical research of ischemic stroke.
